Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma
ClinicalTrials.gov study NCT04469725. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
ClinicalTrials.gov study NCT05395624. IPD Sharing: NO. Countries: 1. Publications: 1.
Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07157306. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
ClinicalTrials.gov study NCT02908906. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Gender and PK-PD of Propofol and Cisatracurium
ClinicalTrials.gov study NCT02588118. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Compare the Effects of Agility and Cycling Exercise Training on Mobility and Balance in PD and Healthy Old Adults
ClinicalTrials.gov study NCT03427762. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC
ClinicalTrials.gov study NCT05400070. IPD Sharing: YES. Countries: 1. Publications: 1.
PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma
ClinicalTrials.gov study NCT03955354. IPD Sharing: YES. Countries: 1. Publications: 2.
ALPN-202 With PD-1 Inhibition in Advanced Malignancies
ClinicalTrials.gov study NCT04920383. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)
ClinicalTrials.gov study NCT04428281. IPD Sharing: YES. Countries: 4. Publications: 1.
PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer
ClinicalTrials.gov study NCT03081715. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
ClinicalTrials.gov study NCT02660008. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
ClinicalTrials.gov study NCT05273827. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Standardization and Optimization of TMS Protocols for the Treatment of PD With Depression or Cognitive Impairment
ClinicalTrials.gov study NCT03552861. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas
ClinicalTrials.gov study NCT01301222. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment
ClinicalTrials.gov study NCT05443230. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)
ClinicalTrials.gov study NCT02588131. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Cost-effectiveness of Nursing Interventions for Patients With PD
ClinicalTrials.gov study NCT03830190. IPD Sharing: NO. Countries: 1. Publications: 5.
A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients
ClinicalTrials.gov study NCT04501276. IPD Sharing: NO. Countries: 2. Publications: 3.
A Clinical Trial for Analysis of Intestinal Microbiome Affecting PK, PD, and Safety of Metformin
ClinicalTrials.gov study NCT03809260. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.